Computer aided diagnostic method and device

a computer and diagnostic method technology, applied in the direction of magnetic variable regulation, measurement using nmr, instruments, etc., can solve the problems of suppressing susceptibility and chemical artifacts, dwi has the disadvantages of susceptibility and chemical shift artifacts, and the adc map is not sufficiently sensitive to establish a stand alone, etc., to reduce the number of phase encoding steps and the time required to fill the k-space, and the effect of excellent contras

Inactive Publication Date: 2015-04-30
ALAN PENN & ASSOCIATES INC
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention relates to methods for generating and characterizing maps or images of regions of a patient's body using diffusion MR image data. These methods can detect benign or malignant lesions in various parts of the body and provide valuable information about the nature of the lesion(s). The technical effects of this invention include improving the accuracy of detecting and characterizing lesions, which can aid in the diagnosis and treatment of cancer.

Problems solved by technology

However, ADC maps are not sufficiently sensitive for establishing a stand alone method for breast cancer detection.
Despite its excellent contrast resolution, DWI has the disadvantages of susceptibility and chemical shift artifacts.
This is probably because the parallel imaging techniques are capable of reducing the number of phase encoding steps and the time required to fill the k-space, which may lead to the suppression of susceptibility and chemical artifacts.
One inherent problem with breast DCE, the current standard method of magnetic resonance imaging, is that enhancing agents are routinely used off-label.
Non-labeled use can result in inconsistency in how the contrast agent is administered.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Computer aided diagnostic method and device
  • Computer aided diagnostic method and device
  • Computer aided diagnostic method and device

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0066]Published studies on breast diffusion imaging have reported that 10%-20% of test cases could not be evaluated because of problems related to the quality of the ADC images. For example, Hatakenaka (“Apparent Diffusion Coefficients of Breast Tumors: Clinical Application,” Magn Reson med Sci, 7(1), pp 23-29 (2008)) reported that “34 [of 179] cases were excluded as a result of small lesions and / or poor visualization of the lesions on DWI,” and Partridge (Diffusion Tensor MRI: Preliminary Anisotropy Measures and Mapping of Breast Tumors,” J Mag Res Imag 31, pp 339-347 (2010)) reported that “19 [of 158 lesions] were excluded because of technical problems with the DTI sequence—misregistration (N=15), poor fat suppression (N=2), or incomplete coverage of the lesion (N=2).”

[0067]The present invention provides a method and device that uses diffusion data to generate alternative images to ADC images for the detection and evaluation of possibly cancerous lesions.

[0068]The method and devic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A method for characterizing regions on a map or image generated from diffusion image data of a region of a patient's body, including: loading into a data processing device image data achieved by calculation from MR diffusion imaging; providing a first threshold level to distinguish pixels with image data values that are above or below the values found that are not representative of pathological portions of the region; providing a second threshold level higher than the first threshold; deriving a measure related to the gradient pattern of those pixels that lie within a margin zone defined by those pixels that satisfy a criterion of the second threshold but do not satisfy a criterion of the first threshold and; outputting the measure related to the gradient as a parameter indicative of the likelihood that the pixels that are within the margin zone and / or a region of the body part are cancerous.

Description

[0001]This invention was made with U.S. Government support under contract number HHSN261201100075C awarded by National Institutes of Health (NIH). The U.S. Government has certain rights in the invention.BACKGROUND OF THE INVENTION[0002]The present invention relates to a method and device for estimating the likelihood that an image of a body or body part obtained through Diffusion Tensor Imaging (DTI) or Diffusion Weighted Imaging (DWI) contains a lesion and further estimating the likelihood that the lesion is cancer.[0003]The known technique of diffusion imaging is disclosed in U.S. Patent Application Publication No. 20100298692A1, the disclosure of which is incorporated herein by reference.[0004]Background in Breast MRI Methods and Terminology:[0005]The invention is applicable to a plurality of parts of the body. For the sake of clarity, the background and description will be described in terms of detection and diagnosis of breast cancer. It is to be understood that this descriptio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): G06F19/00G01R33/48G01R33/28A61B5/055
CPCG06F19/345G01R33/281G01R33/48A61B5/055G01R33/56341G16H50/20
Inventor PENN, ALAN
Owner ALAN PENN & ASSOCIATES INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products